This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
HEXO Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for HEXO.
Wichtige Informationen
83.6%
Wachstumsrate der Gewinne
85.0%
EPS-Wachstumsrate
| Pharmaceuticals Gewinnwachstum | 21.5% |
| Wachstumsrate der Einnahmen | -0.7% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 22 Jun 2023 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 7/31/2025 | 121 | -19 | 48 | 40 | 2 |
| 7/31/2024 | 108 | -24 | 35 | 23 | 2 |
| 7/31/2023 | 103 | -198 | -4 | 16 | 2 |
| 4/30/2023 | 124 | -273 | -48 | -39 | N/A |
| 1/31/2023 | 148 | -301 | -63 | -48 | N/A |
| 10/31/2022 | 177 | -1,013 | -101 | -89 | N/A |
| 7/31/2022 | 191 | -1,074 | -151 | -117 | N/A |
| 4/30/2022 | 187 | -1,042 | -181 | -127 | N/A |
| 1/31/2022 | 164 | -918 | -169 | -121 | N/A |
| 10/31/2021 | 144 | -228 | -148 | -93 | N/A |
| 7/31/2021 | 124 | -115 | -75 | -43 | N/A |
| 4/30/2021 | 112 | -214 | -41 | -18 | N/A |
| 1/31/2021 | 112 | -213 | -66 | -23 | N/A |
| 10/31/2020 | 96 | -491 | -133 | -66 | N/A |
| 7/31/2020 | 81 | -546 | -204 | -95 | N/A |
| 4/30/2020 | 69 | -423 | -307 | -174 | N/A |
| 1/31/2020 | 60 | -411 | -324 | -175 | N/A |
| 10/31/2019 | 56 | -117 | -299 | -138 | N/A |
| 7/31/2019 | 48 | -70 | -266 | -125 | N/A |
| 4/30/2019 | 34 | -35 | -182 | -55 | N/A |
| 1/31/2019 | 22 | -30 | -155 | -51 | N/A |
| 10/31/2018 | 9 | -34 | -110 | -42 | N/A |
| 7/31/2018 | 5 | -23 | -70 | -22 | N/A |
| 4/30/2018 | 4 | -12 | -39 | -13 | N/A |
| 1/31/2018 | 4 | -22 | -22 | -10 | N/A |
| 10/31/2017 | 4 | -14 | -14 | -6 | N/A |
| 7/31/2017 | 4 | -12 | -9 | -5 | N/A |
| 4/30/2017 | 4 | -15 | -8 | -4 | N/A |
| 1/31/2017 | 4 | -3 | N/A | -4 | N/A |
| 10/31/2016 | 3 | -3 | N/A | -3 | N/A |
| 7/31/2016 | 2 | -3 | N/A | -3 | N/A |
| 7/31/2015 | 0 | -3 | N/A | -2 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 74H is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: 74H is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: 74H is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: 74H's revenue is expected to decline over the next 3 years (-0.7% per year).
Hohe Wachstumseinnahmen: 74H's revenue is forecast to decline over the next 3 years (-0.7% per year).
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if 74H's Return on Equity is forecast to be high in 3 years time